Clinical Trials Sponsored by Wen Luo

Total 6433 results

1
2
3
4
5
6
7
8
9
10
...
128
129
›

Wei LUO

Unknown

Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis

Nasopharyngeal Cancers

China
Wen Luo

Completed

Radiographic Evaluation of a Star-shaped Incision Technique

Implant | Thin-gingiva | Clinical and Radiographic Effect | Thick-gingiva

China
Wen Luo

Completed

Clinical and Radiographic Evaluation of a Cross-shaped Incision Technique

Thin Gingiva | Implant | Clinical and Radiographic Effect | Thick-gingiva

China
Wen-huo Chen

Completed

Endovascular Treatment for AIS in Chinese Municipal and County Hospitals： A "Real World" Study-ETERNITY Registry

Endovascular Treatment

China
Wen-huo Chen

Recruiting

Endovascular Treatment for Mild Ischemic Stroke Due to Acute Large Vessel Occlusion in the Anterior Circulation (Mild-MT)

Mild Stroke | Endovascular Treatment

China
Wen-Kai Weng

Completed

Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma

Multiple Myeloma | Blood Cancer

United States
Luo Dingcun

Not yet recruiting

Clinical Study of Ultrasonic Artificial Intelligence and Fine Needle Aspiration in Qualitative Diagnosis of Thyroid Nodules

Thyroid Nodule
Chengcheng Guo

Recruiting

Surveillance of Association of Immune Status and Prognosis of CNS Germ Cell Tumor Survivors

Surgery | Intracranial Germ Cell Tumor | Intracranial Germ Cell CNS Tumor, Childhood

China
Sen-wei Lu

Recruiting

MNK Therapy in Releasing the Superficial Fascia for Patients With AAS: an Assessor-blinded, Randomised Controlled Trial

Acute Ankle Sprain

China
Xiaoping Luo

Recruiting

Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)

Childhood Short Stature

China
GUO WEI

Completed

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Osteosarcoma | Metastasis

China
Ailin Luo

Recruiting

The Safety of Etomidate - Propofol Mixture vs Propofol in Total Intravenous Anesthesia During Abdominal Surgery

Hypotension | Etomidate

China
Luo Dingcun

Unknown

Protein Classifier for Thyroid Indeterminate Nodules

Thyroid Nodule

China
LUN WEI LIU
Chi Mei Medical Hospital

Completed

Effects of Recruitment Maneuvers in Early Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) Patients

Acute Respiratory Distress Syndrome | Lung Injury, Acute

Taiwan
Zhongguang Luo, MD

Not yet recruiting

Endoscopic Cryoablation Combined with PD-1 in Advanced Gastric Cancer

Gastric Cancer

China
Luo Cong

Completed

The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Pancreatic Cancer

China
Luo Cong

Completed

Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical Resection (PaC)

Pancreatic Cancer

China
Luo yanrong

Completed

Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma

Drug-Related Side Effects and Adverse Reactions

China
Wei Guo
Sun Yat-sen University

Completed

Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

China
Zhiyi Zuo
Sun Yat-sen University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Effects of Amantadine on Postoperative Cognitive Dysfunction

Postoperative Cognitive Dysfunction

China
Zhiyi Zuo
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Dexmedetomidine on Segmental EEG Power Spectra

Anesthesia | EEG Power Spectra

China
WenBo Guo

Recruiting

Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy (ROSE)

Hepatocellular Carcinoma | Regorafenib | Transcatheter Arterial ChEmoembolization

China
Zhen-Hai Lu

Recruiting

Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer

Advanced Rectal Cancer

China
wen yu Kuo, assistant professor
Chang Gung Memorial Hospital; National Science and Technology Council

Completed

Family-centered Support Program for Caregivers of Stroke Survivors

Stroke | Caregiver Burden

Taiwan
LEO Pharma

Recruiting

A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968

Joint Pain | Gout Flares | Joint Inflammation

United Kingdom, France
LEO Pharma

Completed

Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema (DELTA TEEN)

Chronic Hand Eczema

Belgium, Poland, Spain, United Kingdom, France, Australia, Canada
LEO Pharma

Completed

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Atopic Dermatitis

United States, Belgium, Canada, Czechia, France, Germany, Italy, Japan, Poland, Spain, United Kingdom
LEO Pharma

Active, not recruiting

Adjusted Brodalumab Dose Compared with Standard Brodalumab Dose in Subjects with Moderate-to-severe Plaque Psoriasis and ≥120 Kg Body Weight (ADJUST)

Psoriasis Vulgaris

Belgium, Czechia, Germany, Italy, Poland, Spain, Greece, Hungary, France, Netherlands, United Kingdom
LEO Pharma

Completed

A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects

Atopic Dermatitis

United States
LEO Pharma

Completed

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

Atopic Dermatitis

United Kingdom
LEO Pharma

Completed

Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream

Healthy Volunteers

Germany
LEO Pharma

Completed

A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris

Skin and Connective Tissue Diseases

France
LEO Pharma

Completed

Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

Atopic Dermatitis

United States, Belgium, Canada, Australia, France, Germany, Japan, Netherlands, Poland, United Kingdom
LEO Pharma

Completed

Investigating the Safety of LEO 158968 in Healthy Volunteers

Healthy Volunteers

Netherlands
LEO Pharma

Completed

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

Chronic Hand Eczema

United States, Germany, Denmark
LEO Pharma

Terminated

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab (COBRA)

Psoriasis | Plaque Psoriasis | Psoriasis Vulgaris

Belgium, Germany, Italy, Spain, Denmark, Austria, France, Greece, Switzerland, United Kingdom, Netherlands, Sweden
LEO Pharma

Completed

Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA) (INJECZTRA)

Atopic Dermatitis

United States
LEO Pharma

Completed

Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema

Chronic Hand Eczema

Germany
LEO Pharma

Completed

A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People

Healthy Volunteers

United Kingdom
LEO Pharma

Completed

Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream

Healthy Volunteers

Germany
LEO Pharma

Completed

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) (ECZTRA 5)

Atopic Dermatitis

United States, Canada
LEO Pharma

Completed

Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema

Hand Eczema

Germany
LEO Pharma

Completed

A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis

Stable Plaque Psoriasis

China
LEO Pharma

Completed

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Atopic Dermatitis

United States, Canada, Germany, Poland
LEO Pharma

Completed

Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin

Healthy

Germany
LEO Pharma

Terminated

Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis

Disseminated Intravascular Coagulation
LEO Pharma

Completed

Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis

Actinic Keratosis

United States
LEO Pharma

Completed

Body PSOriasis: Long-term Relapse CONTROL (PSO-CONTROL)

Psoriasis Vulgaris

Russian Federation
LEO Pharma

Completed

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.

Psoriasis Vulgaris

Germany
LEO Pharma

Completed

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Psoriasis Vulgaris

United States, Canada, Germany, United Kingdom, France, Poland

1
2
3
4
5
6
7
8
9
10
...
128
129
›

3

Subscribe